Progressive Cellular Senescence Mediates Renal Dysfunction in Ischemic Nephropathy

Autor: Alireza Khodadadi-Jamayran, Stephen C. Textor, Timothy B. Niewold, Xiangyang Zhu, Ian Taylor, Amir Lerman, Tamara Tchkonia, Lilach O. Lerman, Xiao Jun Chen, James L. Kirkland, Amrutesh S. Puranik, Seo Rin Kim, La Tonya J. Hickson, Bennett G. Childs, Kai Jiang
Rok vydání: 2021
Předmět:
Male
0301 basic medicine
Dasatinib
Gene Expression
Apoptosis
Kidney
Renal artery stenosis
Mice
0302 clinical medicine
Ischemia
CDKN2A
Cellular Senescence
Caspase 8
General Medicine
Up-Regulation
Nephrology
030220 oncology & carcinogenesis
Single-Cell Analysis
Heparin-binding EGF-like Growth Factor
Cyclin-Dependent Kinase Inhibitor p21
Senescence
Epithelial-Mesenchymal Transition
Mice
Transgenic

Renal Artery Obstruction
Tacrolimus
03 medical and health sciences
Downregulation and upregulation
medicine
Animals
Humans
Cyclin-Dependent Kinase Inhibitor p19
Renal Insufficiency
Chronic

Senolytic
Protein Kinase Inhibitors
Cyclin-Dependent Kinase Inhibitor p16
Renal ischemia
Sequence Analysis
RNA

business.industry
Mesenchymal stem cell
Epithelial Cells
medicine.disease
Enzyme Activation
Mice
Inbred C57BL

Disease Models
Animal

Basic Research
030104 developmental biology
p21-Activated Kinases
Chronic Disease
Cancer research
Osteopontin
business
Zdroj: J Am Soc Nephrol
ISSN: 1533-3450
1046-6673
Popis: BACKGROUND: Peripheral vascular diseases may induce chronic ischemia and cellular injury distal to the arterial obstruction. Cellular senescence involves proliferation arrest in response to stress, which can damage neighboring cells. Renal artery stenosis (RAS) induces stenotic-kidney dysfunction and injury, but whether these arise from cellular senescenceand their temporal pattern remain unknown. METHODS: Chronic renal ischemia was induced in transgenic INK-ATTAC and wild type C57BL/6 mice by unilateral RAS, and kidney function (in vivo micro-MRI) and tissue damage were assessed. Mouse healthy and stenotic kidneys were analyzed using unbiased single-cell RNA-sequencing. To demonstrate translational relevance, cellular senescence was studied in human stenotic kidneys. RESULTS: Using intraperitoneal AP20187 injections starting 1, 2, or 4 weeks after RAS, selective clearance of cells highly expressing p16(Ink4a) attenuated cellular senescence and improved stenotic-kidney function; however, starting treatment immediately after RAS induction was unsuccessful. Broader clearance of senescent cells, using the oral senolytic combination dasatinib and quercetin, in C57BL/6 RAS mice was more effective in clearing cells positive for p21 (Cdkn1a) and alleviating renal dysfunction and damage. Unbiased, single-cell RNA sequencing in freshly dissociated cells from healthy and stenotic mouse kidneys identified stenotic-kidney epithelial cells undergoing both mesenchymal transition and senescence. As in mice, injured human stenotic kidneys exhibited cellular senescence, suggesting this process is conserved. CONCLUSIONS: Maladaptive tubular cell senescence, involving upregulated p16 (Cdkn2a), p19 (Cdkn2d), and p21 (Cdkn1a) expression, is associated with renal dysfunction and injury in chronic ischemia. These findings support development of senolytic strategies to delay chronic ischemic renal injury.
Databáze: OpenAIRE